Proteomics of tear fluid in thyroid-associated orbitopathy

Thyroid

Volumn 22, Issue 10, 2012, Pages 1039-1045

  Matheis, Nina ^a   Okrojek, Rainer ^a   Grus, Franz H ^a   Kahaly, George J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CYSTATIN S; LEVOTHYROXINE; PEPTIDE; PROLINE; THIAMAZOLE;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENDOCRINE OPHTHALMOPATHY; FEMALE; HASHIMOTO DISEASE; HUMAN; LACRIMAL FLUID; LACRIMAL GLAND; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEOMICS; SCORING SYSTEM; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; THYROID DISEASE; UPREGULATION;

ADULT; AGED; BETA 2-MICROGLOBULIN; DOWN-REGULATION; EYE PROTEINS; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; LACRIMAL APPARATUS; MALE; MIDDLE AGED; MURAMIDASE; PEPTIDES; PROTEOMICS; SALIVARY CYSTATINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TEARS; UP-REGULATION;

EID: 84866989207     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0119     Document Type: Article

References (41)

1. Anderson NL, Anderson NG 1998 Proteome and pro-teomics: new technologies, new concepts, and new words. Electrophoresis 19:1853-1861. (Pubitemid 28392230)
2. Aebersold R, Mann M 2003 Mass spectrometry-based pro-teomics. Nature 422:198-207.
3. Grus FH, Podust VN, Bruns K, Lackner K, Fu S, Dalmasso EA, Wirthlin A, Pfeiffer N 2005 SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci 46:863-876. (Pubitemid 41321022)
4. Bahn RS 2010 Graves' ophthalmopathy. N Engl J Med 362:726-738.
5. Bahn RS, Heufelder AE 1993 Pathogenesis of Graves' oph-thalmopathy. N Engl J Med 329:1468-1475.
6. Bartalena L 2011 The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy. J Clin Endocrinol Metab 96:592-599.
7. Bartalena L, Tanda ML 2009 Clinical practice. Graves' oph-thalmopathy. N Engl J Med 360:994-1001.
8. Chang TC, Huang KM, Chang TJ, Lin SL 1990 Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease. Clin Endocrinol (Oxf) 32:551-558. (Pubitemid 20151450)
9. Moncayo R, Baldissera I, Decristoforo C, Kendler D, Don-nemiller E 1997 Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionu-clide imaging using the somatostatin analog 111In-octreotide. Thyroid 7:21-29. (Pubitemid 27132891)
10. Eckstein AK, Finkenrath A, Heiligenhaus A, Renzing-Kohler K, Esser J, Kruger C, Quadbeck B, Steuhl KP, Gieseler RK 2004 Dry eye syndrome in thyroid-associated ophthalmo-pathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand 82:291-297. (Pubitemid 38714645)
11. Baker GR, Morton M, Rajapaska RS, Bullock M, Gullu S, Mazzi B, Ludgate M 2006 Altered tear composition in smokers and patients with graves ophthalmopathy. Arch Ophthalmol 124:1451-1456. (Pubitemid 44537146)
12. Khalil HA, De Keizer RJ, Bodelier VM, Kijlstra A 1989 Secretory IgA and lysozyme in tears of patients with Graves' ophthalmopathy. Doc Ophthalmol 72:329-334. (Pubitemid 20072238)
13. Ujhelyi B, Gogolak P, Erdei A, Nagy V, Balazs E, Rajna-volgyi E, Berta A, Nagy EV 2012 Graves' orbitopathy results in profound changes in tear composition: a study of plas-minogen activator inhibitor-1 and seven cytokines. Thyroid 22:407-414.
14. Okrojek R, Grus FH, Matheis N, Kahaly GJ 2009 Proteomics in autoimmune thyroid eye disease. Horm Metab Res 41:465-470.
15. Wiersinga WM, Perros P, Kahaly GJ, Mourits MP, Baldeschi L, Boboridis K, Boschi A, Dickinson AJ, Kendall-Taylor P, Krassas GE, Lane CM, Lazarus JH, Marcocci C, Marino M, Nardi M, Neoh C, Orgiazzi J, Pinchera A, Pitz S, Prummel MF, Sartini MS, Stahl M, von Arx G 2006 Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists, and clinical researchers. Eur J Endocrinol 155:387-389. (Pubitemid 44463943)
16. Koo BS, Lee DY, Ha HS, Kim JC, Kim CW 2005 Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis. J Proteome Res 4:719-724.
17. Dogru M, Katakami C, Inoue M 2001 Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 108:586-592. (Pubitemid 32179902)
18. Herber S, Grus FH, Sabuncuo P, Augustin AJ 2001 Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis 22:1838-1844.
19. Herber S, Grus FH, Sabuncuo P, Augustin AJ 2002 Changes in the tear protein patterns of diabetic patients using two-dimensional electrophoresis. Adv Exp Med Biol 506:623-626. (Pubitemid 36312998)
20. Evans V, Vockler C, Friedlander M, Walsh B, Willcox MD 2001 Lacryglobin in human tears, a potential marker for cancer. Clin Exp Ophthalmol 29:161-163. (Pubitemid 32618981)
21. Khalil HA, de Keizer RJ, Kijlstra A 1988 Analysis of tear proteins in Graves' ophthalmopathy by high performance liquid chromatography. Am J Ophthalmol 106:186-190.
22. Reitz C, Breipohl W, Augustin A, Bours J 1998 Analysis of tear proteins by one-and two-dimensional thin-layer ioso-electric focusing, sodium dodecyl sulfate electrophoresis and lectin blotting. Detection of a new component: cystatin C. Graefes Arch Clin Exp Ophthalmol 236:894-899. (Pubitemid 28546503)
23. Schmut O, Horwath-Winter J, Zenker A, Trummer G 2002 The effect of sample treatment on separation profiles of tear fluid proteins: qualitative and semi-quantitative protein determination by an automated analysis system. Graefes Arch Clin Exp Ophthalmol 240:900-905. (Pubitemid 36097112)
24. Kramann C, Boehm N, Lorenz K, Wehrwein N, Stoffelns BM, Pfeiffer N, Grus FH 2011 Effect of contact lenses on the protein composition in tear film: a ProteinChip study. Graefes Arch Clin Exp Ophthalmol 249:233-243.
25. Hortin GL 2006 The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem 52:1223-1237. (Pubitemid 43956011)
26. Petricoin EF, Belluco C, Araujo RP, Liotta LA 2006 The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat Rev Cancer 6:961-967. (Pubitemid 44862680)
27. Zhang B, Nie X, Xiao B, Xiang J, Shen S, Gong J, Zhou M, Zhu S, Zhou J, Qian J, Lu H, He X, Li X, Hu G, Li G 2003 Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosomes Cancer 38:80-90. (Pubitemid 36994886)
28. Bennick A 1987 Structural and genetic aspects of proline-rich proteins. J Dent Res 66:457-461.
29. Dickinson DP, Thiesse M 1995 A major human lacrimal gland mRNA encodes a new proline-rich protein family member. Invest Ophthalmol Vis Sci 36:2020-2031.
30. Galoyan AA, Sarkissian JS, Chavushyan VA, Sulkhanyan RM, Avakyan ZE, Avetisyan ZA, Grigorian Y, Abrahamyan DO 2005 Neuroprotective action of hypothalamic peptide PRP-1 at various time survivals following spinal cord hemisection. Neurochem Res 30:507-525. (Pubitemid 40933659)
31. Cresswell P, Springer T, Strominger JL, Turner MJ, Grey HM, Kubo RT 1974 Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci USA 71:2123-2127.
32. Rammensee HG, Robinson PJ, Crisanti A, Bevan MJ 1986 Restricted recognition of beta 2-microglobulin by cytotoxic T lymphocytes. Nature 319:502-504. (Pubitemid 16212931)
33. Wiesner J,Vilcinskas A 2010 Antimicrobial peptides: the ancient arm of the human immune system. Virulence 1: 440-464.
34. 2-microglobulin-free MHC class I molecules in T cell Immunoregulation. Int J Clin Lab Res 23:61-69.
35. Fung KY, Morris C, Sathe S, Sack R, Duncan MW 2004 Characterization of the in vivo forms of lacrimal-specific proline-rich proteins in human tear fluid. Proteomics 4:3953-3959. (Pubitemid 39657470)
36. Torsteinsdottir I, Hakansson L, Hallgren R, Gudbjornsson B, Arvidson NG, Venge P 1999 Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis. Rheumatology (Oxf) 38:1249-1254.
37. Anastasi A, Brown MA, Kembhavi AA, Nicklin MJ, Sayers CA, Sunter DC, Barrett AJ 1983 Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum. Biochem J 211:129-138. (Pubitemid 13104394)
38. Barka T, Asbell PA, van der Noen H, Prasad A 1991 Cy-statins in human tear fluid. Curr Eye Res 10:25-34.
39. de Souza GA, Godoy LM, Mann M 2006 Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol 7:R72.
40. Ananthi S, Chitra T, Bini R, Prajna NV, Lalitha P, Dharma-lingam K 2008 Comparative analysis of the tear protein profile in mycotic keratitis patients. Mol Vis 14:500-507. (Pubitemid 351486085)
41. Bokenkamp A, van Wijk JA, Lentze MJ, Stoffel-Wagner B 2002 Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations. Clin Chem 48:1123-1126. (Pubitemid 34680918)